Health Sciences Gr Stock Buy Hold or Sell Recommendation
Given the investment horizon of 90 days and your way above-average risk tolerance, our recommendation regarding Health Sciences Gr is 'Strong Sell'. Macroaxis provides Health Sciences buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding HESG positions.
Check out Health Sciences Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as Health and provide practical buy, sell, or hold advice based on investors' constraints. Health Sciences Gr. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.
Health |
Execute Health Sciences Buy or Sell Advice
The Health recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Health Sciences Gr. Macroaxis does not own or have any residual interests in Health Sciences Gr or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Health Sciences' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Not Rated
Health Sciences Trading Alerts and Improvement Suggestions
| Health Sciences Gr generated a negative expected return over the last 90 days | |
| Health Sciences Gr has some characteristics of a very speculative penny stock | |
| Health Sciences Gr has high likelihood to experience some financial distress in the next 2 years | |
| Health Sciences Gr currently holds 407 K in liabilities. Health Sciences Gr has a current ratio of 0.01, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Health Sciences until it has trouble settling it off, either with new capital or with free cash flow. So, Health Sciences' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Health Sciences Gr sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Health to invest in growth at high rates of return. When we think about Health Sciences' use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 358.43 K. Net Loss for the year was (54.49 K) with profit before overhead, payroll, taxes, and interest of 22.91 K. |
Health Sciences Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Health Sciences or Food & Staples Retailing sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Health Sciences' price will be affected by overall pink sheet market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Health pink sheet's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.00 | |
β | Beta against Dow Jones | 0.00 | |
σ | Overall volatility | 0.00 | |
Ir | Information ratio | 0.00 |
Health Sciences Volatility Alert
At this time Health Sciences Gr exhibits very low volatility. You can indeed make money on Health instrument if you perfectly time your entry and exit. However, remember that penny pink sheets that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Health Sciences Fundamentals Vs Peers
Comparing Health Sciences' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Health Sciences' direct or indirect competition across all of the common fundamentals between Health Sciences and the related equities. This way, we can detect undervalued stocks with similar characteristics as Health Sciences or determine the pink sheets which would be an excellent addition to an existing portfolio. Peer analysis of Health Sciences' fundamental indicators could also be used in its relative valuation, which is a method of valuing Health Sciences by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Health Sciences to competition |
| Fundamentals | Health Sciences | Peer Average |
| Return On Asset | -0.73 | -0.14 |
| Operating Margin | (73.91) % | (5.51) % |
| Current Valuation | 39.41 K | 16.62 B |
| Price To Sales | 0 X | 11.42 X |
| Revenue | 358.43 K | 9.43 B |
| Gross Profit | 22.91 K | 27.38 B |
| EBITDA | (4.51 M) | 3.9 B |
| Net Income | (54.49 K) | 570.98 M |
| Cash And Equivalents | 1.71 K | 2.7 B |
| Total Debt | 407 K | 5.32 B |
| Current Ratio | 0.01 X | 2.16 X |
| Book Value Per Share | (0.11) X | 1.93 K |
| Cash Flow From Operations | 38.99 K | 971.22 M |
| Earnings Per Share | (0.13) X | 3.12 X |
| Number Of Employees | 2 | 18.84 K |
| Beta | -28.36 | -0.15 |
| Market Capitalization | 281 | 19.03 B |
| Total Asset | 1.03 M | 29.47 B |
| Retained Earnings | (32.46 M) | 9.33 B |
| Working Capital | (5.04 M) | 1.48 B |
| Current Asset | 67 K | 9.34 B |
| Current Liabilities | 5.11 M | 7.9 B |
| Z Score | -61.4 | 8.72 |
| Annual Yield | 0.05 % | |
| Net Asset | 1.03 M |
About Health Sciences Buy or Sell Advice
When is the right time to buy or sell Health Sciences Gr? Buying financial instruments such as Health Pink Sheet isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Health Sciences in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Agency Mbs ETFs Thematic Idea Now
Agency Mbs ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Agency Mbs ETFs theme has 11 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Agency Mbs ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Health Pink Sheet
Health Sciences financial ratios help investors to determine whether Health Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Health with respect to the benefits of owning Health Sciences security.